Independent association of atherogenic dyslipidaemia with all-cause mortality in individuals with type 2 diabetes and modifying effect of gender: a prospective cohort study.

Emanuela OrsiGiuseppe PennoAnna SoliniEnzo BonoraCecilia FondelliRoberto TrevisanMonica VedovatoFranco CavalotSusanna MoranoMarco G BaroniAntonio NicolucciGiuseppe Pugliesenull null

Published in: Cardiovascular diabetology (2021)

In patients with type 2 diabetes, higher triglycerides and TG:HDL and lower HDL cholesterol were independently associated with increased all-cause mortality, with a modifying effect of gender for triglycerides and HDL cholesterol. These data suggest that atherogenic dyslipidaemia, especially TG:HDL, may serve as predictor of all-cause death in these individuals. Trial registration ClinicalTrials.gov, NCT00715481, 15 July, 2008.

Keyphrases

low density lipoprotein
mental health
clinical trial
study protocol
phase iii
machine learning
big data
artificial intelligence
deep learning